Dkk-3 was found to enhance PDAC metastasis and interfere with chemotherapy resistance, while a combination of a Dkk-3 function blocking antibody, JM6-6-1, and immune checkpoint inhibitors was found to limit tumor growth and survival [19]. Here, DKK3 is linked to neoplasm.